Fundz

Reva Medical Announces Closing Of Strategic Financing

PRIVATEAug 09, 2022

Round Type

Funding Round

San DiegoManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

REVA Medical, LLC. ("REVA" or the "Company"), a leader in bioresorbable polymer technologies for vascular applications, is pleased to announce the closing of a $45 million Series B equity financing. This funding was led by a global strategic investor with deep experience in medical devices, as well as BioStar Capital, and existing investors.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as REVA Medical that raised within 45 days of this round, from Fundz verified event records.

  • Neochord raised $2.9M (Seed) on September 8, 2022.
  • Monteris Medical raised $14M on September 2, 2022.
  • Xtant Medical Holdings raised $9.8M on August 24, 2022.
  • Levita Magnetics International Corp. raised $26M (Funding Round) on August 11, 2022.
  • Medcura raised $3.2M on July 29, 2022.
  • Flyte Aviation, Inc. raised $6.2M (Funding Round) on July 22, 2022.

Who to call at REVA Medical, and when

A new round usually means REVA Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day REVA Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at REVA Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at REVA Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

REVA Medical

Location

Copley Drive

San Diego, California, United States

About

REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company's products include MOTIV bioresorbable scaffolds for the treatment of peripheral artery disease, Fantom and Fantom Encore bioresorbable vascular scaffolds for the treatment of coronary artery disease, and TyroSphere embolic beads. REVA is based in San Diego, California. More information can be found at REVA's website: www.revamedical.com. Fantom, Fantom Encore, and MOTIV have CE Mark only. Fantom, Fantom Encore, and MOTIV are available in select countries in Europe and the Middle East. Fantom, Fantom Encore, MOTIV, and TyroSphere are not available in the U.S. or other countries that do not accept CE Mark. Fantom, Fantom Encore, MOTIV, TyroSphere, and Tyrocore are trademarks of REVA Medical, LLC. SOURCE REVA Medical, LLC

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment REVA Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for REVA Medical's next move

See what Strategic adds

REVA Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.